|
Bogolepova A.N., Osinovskaya N.A.
Asthenic disorders in the context of COVID-19 pandemic
|
№9 / 2022
|
|
Koltsov I.A., Shchukin I.A., Chubykin V.I., Fidler M.S.
Neuroinflammation and thromboinflammation in cerebrovascular disease and vascular cognitive impairment
|
№9 / 2022
|
|
Grinevich V.B., Kravchuk Yu.A., Egorov D.V., Ivanyuk E.S., Plisikova N.A.
Clinical effectiveness of the probiotic containing B. longum, B. breve, L. rhamnosus, L. acidophilus in the treatment of irritable bowel syndrome with diarrhea
|
№7 / 2022
|
|
Kamchatnov P.R., Khanmurzayeva S.B., Chugunov A.V., Khanmurzayeva N.B.
Neurological aspects of the postcovide syndrome
|
№3 / 2022
|
|
Zakharov V.V., Gromova D.O.
Neurological manifestations of post-covid syndrome
|
№1 / 2022
|
|
Malyavin A.G.
Consequences of COVID-19: prevalence and approaches to Long-COVID symptoms therapy
|
№10 / 2021
|
|
Shishkova V.N., Kotova M.B., Kapustina L.A., Imamgayazova K.E.
Issues of pathogenesis of cognitive and psychoemotional disorders in patients with cardiovascular and metabolic diseases
|
№8 / 2021
|
|
A.G. Yevdokimova, Ye.S. Kiparisova, Ye.V. Kovalenko, V.V. Yevdokimov, L.I. Markova, K.I. Tebloev, I.V. Larina, A.I. Martynov
Рrevention and treatment of cognitive disorders in patients with hypertensive encephalopathy
|
№4 / 2017
|
|
M.A. Domashenko, D.V. Sergeev
Efficiency of citicoline in the therapy of cognitive and motor disorders in patients in the early recovery period of stroke
|
№5 / 2016
|
Русский
